Literature DB >> 19840773

Galanin is highly expressed in bone marrow mesenchymal stem cells and facilitates migration of cells both in vitro and in vivo.

Marisa Louridas1, Sevan Letourneau, Maria-Elena Lautatzis, Maria Vrontakis.   

Abstract

Galanin peptide has recently been found to be highly abundant in early embryonic mouse mesenchyme, while galanin and its receptors are expressed in embryonic mouse stem cells. Bone marrow mesenchymal stem cells (BMMSCs) represent the primary source for adult stem cell therapy. In this study we examined the abundance of galanin and its receptors in BMMSCs and evaluated its possible function. Galanin mRNA and protein were highly expressed in BMMSCs cultures up to four passages, while among the three galanin receptor subtypes (GalR1, GalR2, and GalR3) only GalR2 and to a lesser extent GalR3 were expressed. Using chemotaxis and wound assays we found that galanin protein increased the migration of BMMSCs. Furthermore, increased serum galanin levels in a galanin transgenic model enhanced the mobilization (homing) of injected BMMSCs in vivo. These data suggest a role for galanin in BMMSC migration, probably through activation of the GalR2 receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19840773     DOI: 10.1016/j.bbrc.2009.10.064

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Neuronal hypothalamic regulation of body metabolism and bone density is galanin dependent.

Authors:  Anna Idelevich; Kazusa Sato; Kenichi Nagano; Glenn Rowe; Francesca Gori; Roland Baron
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

Review 2.  Stem cell homing in musculoskeletal injury.

Authors:  Eliza L S Fong; Casey K Chan; Stuart B Goodman
Journal:  Biomaterials       Date:  2010-10-08       Impact factor: 12.479

Review 3.  The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration.

Authors:  Vijay Bhaskar Reddy Konala; Murali Krishna Mamidi; Ramesh Bhonde; Anjan Kumar Das; Radhika Pochampally; Rajarshi Pal
Journal:  Cytotherapy       Date:  2015-11-26       Impact factor: 5.414

4.  The Neuropeptide Spexin Promotes the Osteoblast Differentiation of MC3T3-E1 Cells via the MEK/ERK Pathway and Bone Regeneration in a Mouse Calvarial Defect Model.

Authors:  Freshet Assefa; Ju Ang Kim; Jiwon Lim; Sang-Hyeon Nam; Hong-In Shin; Eui Kyun Park
Journal:  Tissue Eng Regen Med       Date:  2021-12-24       Impact factor: 4.169

Review 5.  Cellular targets for neuropeptide Y-mediated control of adult neurogenesis.

Authors:  Maria Concetta Geloso; Valentina Corvino; Valentina Di Maria; Elisa Marchese; Fabrizio Michetti
Journal:  Front Cell Neurosci       Date:  2015-03-16       Impact factor: 5.505

6.  Identification and Evaluation of New Immunoregulatory Genes in Mesenchymal Stromal Cells of Different Origins: Comparison of Normal and Inflammatory Conditions.

Authors:  Mohammad Fayyad-Kazan; Mehdi Najar; Hussein Fayyad-Kazan; Gordana Raicevic; Laurence Lagneaux
Journal:  Med Sci Monit Basic Res       Date:  2017-03-24

7.  Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancer.

Authors:  Leanne Stevenson; Wendy L Allen; Richard Turkington; Puthen V Jithesh; Irina Proutski; Gail Stewart; Heinz-Josef Lenz; Sandra Van Schaeybroeck; Daniel B Longley; Patrick G Johnston
Journal:  Clin Cancer Res       Date:  2012-08-02       Impact factor: 12.531

Review 8.  Neuroendocrine Factors in Melanoma Pathogenesis.

Authors:  Cristian Scheau; Carmen Draghici; Mihaela Adriana Ilie; Mihai Lupu; Iulia Solomon; Mircea Tampa; Simona Roxana Georgescu; Ana Caruntu; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

Review 9.  In situ tissue regeneration through host stem cell recruitment.

Authors:  In Kap Ko; Sang Jin Lee; Anthony Atala; James J Yoo
Journal:  Exp Mol Med       Date:  2013-11-15       Impact factor: 8.718

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.